[{"NetIncomeLoss_1_Q2_USD":-58758000.0,"LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_0_Q2_USD":2925000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q2_USD":17.85,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":551000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q2_USD":1500000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-43744000.0,"StockIssuedDuringPeriodValueNewIssues_2_Q2_USD":193948000.0,"LiabilitiesFairValueDisclosure_0_Q2_USD":108000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":3244298.0,"StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_2_Q2_USD":0.0,"StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_1_Q2_USD":0.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":11083000.0,"AssetsCurrent_0_Q2_USD":559409000.0,"OtherNoncashIncomeExpense_2_Q2_USD":39000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":16024847.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":16024847.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":10731000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-3794000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":11447000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":31855000.0,"LessorOperatingLeasePaymentsToBeReceivedThreeYears_0_Q2_USD":3096000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.01,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":193948000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":8424000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.01,"OperatingLeaseRightOfUseAsset_0_Q2_USD":33312000.0,"ShareBasedCompensation_2_Q2_USD":23269000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_0_Q2_USD":13.52,"Assets_0_Q2_USD":647337000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":419626000.0,"CommonStockSharesIssued_0_Q2_shares":105897872.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":19.08,"CommonStockSharesAuthorized_0_Q2_shares":400000000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":104068815.0,"ResearchAndDevelopmentExpense_2_Q2_USD":104168000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":53152000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":15.74,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":102797000.0,"LessorOperatingLeasePaymentsToBeReceived_0_Q2_USD":11337000.0,"AssetsFairValueDisclosure_0_Q2_USD":530827000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":-56000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":79000.0,"InvestmentIncomeNetAmortizationOfDiscountAndPremium_2_Q2_USD":1025000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_2_Q2_USD":201000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_1_Q2_USD":-284000.0,"CommonStockValue_0_Q2_USD":1385000.0,"Revenues_2_Q2_USD":9451000.0,"Revenues_1_Q2_USD":5847000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":4254000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":199328000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":281057000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":13972000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":26527000.0,"MarketableSecuritiesCurrent_0_Q2_USD":412397000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"OperatingLeaseLiability_0_Q2_USD":70942000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_2_Q2_USD":5380000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":105717912.0,"Liabilities_0_Q2_USD":145170000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":137184000.0,"OtherAssetsNoncurrent_0_Q2_USD":3765000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-744000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-59042000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-115320000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_1_Q2_USD":0.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":66612000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":9363000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":5811000.0,"OperatingIncomeLoss_2_Q2_USD":-121244000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":23269000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":12484000.0,"RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_2_Q2_USD":88000.0,"RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_1_Q2_USD":36000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-97849000.0,"MarketableSecuritiesNoncurrent_0_Q2_USD":7229000.0,"LessorOperatingLeasePaymentsToBeReceivedFourYears_0_Q2_USD":876000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":10391000.0,"LiabilitiesCurrent_0_Q2_USD":58464000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_Q2_USD":57735000.0,"AccountsPayableCurrent_0_Q2_USD":1866000.0,"NonoperatingIncomeExpense_2_Q2_USD":5667000.0,"NonoperatingIncomeExpense_1_Q2_USD":2598000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":138684000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":9828000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.09,"LessorOperatingLeasePaymentsToBeReceivedTwoYears_0_Q2_USD":3009000.0,"NetIncomeLoss_2_Q2_USD":-115521000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":43622000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_2_Q2_USD":-100000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":2000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"IncomeLossAttributableToParent_1_Q2_USD":-58679000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":958000.0,"IncomeLossAttributableToParent_2_Q2_USD":-115577000.0,"NumberOfOperatingSegments_2_Q2_Segment":1.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":461968.0,"LesseeOperatingLeaseDiscountRate_0_Q2_pure":0.09,"AdditionalPaidInCapital_0_Q2_USD":1041303000.0,"SubleaseIncome_1_Q2_USD":1000000.0,"SubleaseIncome_2_Q2_USD":1900000.0,"OperatingLeasePayments_2_Q2_USD":4700000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":201000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":-284000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q2_shares":12446239.0,"OperatingExpenses_2_Q2_USD":130695000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":4330000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":232093.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":12484000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":23269000.0,"DerivativeLiabilities_0_Q2_USD":108000.0,"OperatingExpenses_1_Q2_USD":67124000.0,"PreferredStockSharesAuthorized_0_Q2_shares":40000000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":647337000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":7.67,"PreferredStockValue_0_Q2_USD":0.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":24.78,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":34134000.0,"OperatingIncomeLoss_1_Q2_USD":-61277000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":5531000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":5071000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":-2215000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.11,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":323607000.0,"CommonStockSharesOutstanding_0_Q2_shares":105897872.0,"LeaseCost_1_Q2_USD":2900000.0,"LeaseCost_2_Q2_USD":5500000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-541072000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":5318846.0,"LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear_0_Q2_USD":1431000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":14190971.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":1194000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":19715000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_0_Q2_USD":0.0,"StockholdersEquity_0_Q2_USD":502167000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":379000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.56,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":418668000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-8644000.0,"Ticker":"DNLI","CIK":"1714899","name":"DENALI THERAPEUTICS INC.","OfficialName":"Denali Therapeutics Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"3477413158.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20200807"}]